53
Views
0
CrossRef citations to date
0
Altmetric
Original Investigation

The role of the immune system in depersonalisation disorder

, , , , , , , , , & show all
Received 11 Dec 2023, Accepted 18 Apr 2024, Published online: 17 May 2024

References

  • Andersen CBF, Stødkilde K, Sæderup KL, Kuhlee A, Raunser S, Graversen JH, Moestrup SK. 2017. Haptoglobin. Antioxid Redox Signal. 26(14):814–831. doi:10.1089/ars.2016.6793.
  • Aslam MS, Yuan L. 2020. Serpina3n: potential drug and challenges, mini review. J Drug Target. 28(4):368–378. doi:10.1080/1061186X.2019.1693576.
  • Bizik G, Bob P, Raboch J, Pavlat J, Uhrova J, Benakova H, Zima T. 2014. Dissociative symptoms reflect levels of tumor necrosis factor alpha in patients with unipolar depression. Neuropsychiatr Dis Treat. 10:675–679. doi:10.2147/NDT.S50197.
  • Capuron L, Schroecksnadel S, Féart C, Aubert A, Higueret D, Barberger-Gateau P, Layé S, Fuchs D. 2011. Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry. 70(2):175–182. doi:10.1016/j.biopsych.2010.12.006.
  • Chelbi ST, Wilson ML, Veillard AC, Ingles SA, Zhang J, Mondon F, Gascoin-Lachambre G, Doridot L, Mignot TM, Rebourcet R, et al. 2012. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Hum Mol Genet. 21(9):1968–1978. doi:10.1093/hmg/dds006.
  • Choi H, Mun S, Joo EJ, Lee KY, Kang HG, Lee J. 2021. Serum proteomic analysis of major depressive disorder patients and their remission status: novel biomarker set of zinc-alpha-2-glycoprotein and keratin type II cytoskeletal 1. Int J Biol Macromol. 183:2001–2008. doi:10.1016/j.ijbiomac.2021.05.172.
  • Curran HV, Morgan C. 2000. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction. 95(4):575–590. doi:10.1046/j.1360-0443.2000.9545759.x.
  • Del Giudice M, Gangestad SW. 2018. Rethinking IL-6 and CRP: why they are more than inflammatory biomarkers, and why it matters. Brain Behav Immun. 70:61–75. doi:10.1016/j.bbi.2018.02.013.
  • Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR, Charney DS. 1994. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry. 51(11):865–874. doi:10.1001/archpsyc.1994.03950110025005.
  • di Masi A, De Simone G, Ciaccio C, D'Orso S, Coletta M, Ascenzi P. 2020. Haptoglobin: from hemoglobin scavenging to human health. Mol Aspects Med. 73:100851. doi:10.1016/j.mam.2020.100851.
  • Fischer H, Langbein L, Reichelt J, Praetzel-Wunder S, Buchberger M, Ghannadan M, Tschachler E, Eckhart L. 2014. Loss of keratin K2 expression causes aberrant aggregation of K10, hyperkeratosis, and inflammation. J Invest Dermatol. 134(10):2579–2588. doi:10.1038/jid.2014.197.
  • Gao D, Trayhurn P, Bing C. 2010. Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes. Mol Cell Endocrinol. 325(1-2):135–142. doi:10.1016/j.mce.2010.05.020.
  • Geronimo FRB, Barter PJ, Rye KA, Heather AK, Shearston KD, Rodgers KJ. 2016. Plaque stabilizing effects of apolipoprotein A-IV. Atherosclerosis. 251:39–46. doi:10.1016/j.atherosclerosis.2016.04.019.
  • Guralnik O, Giesbrecht T, Knutelska M, Sirroff B, Simeon D. 2007. Cognitive functioning in depersonalization disorder. J Nerv Ment Dis. 195(12):983–988. doi:10.1097/NMD.0b013e31815c19cd.
  • Hack LM, Zhang X, Heifets BD, Suppes T, van Roessel PJ, Yesavage JA, Gray NJ, Hilton R, Bertrand C, Rodriguez CI, et al. 2023. Ketamine’s acute effects on negative brain states are mediated through distinct altered states of consciousness in humans. Nat Commun. 14(1):6631. doi:10.1038/s41467-023-42141-5.
  • Harrison NA, Cooper E, Dowell NG, Keramida G, Voon V, Critchley HD, Cercignani M. 2015. Quantitative magnetization transfer imaging as a biomarker for effects of systemic inflammation on the brain. Biol Psychiatry. 78(1):49–57. doi:10.1016/j.biopsych.2014.09.023.
  • Hassan MI, Waheed A, Yadav S, Singh TP, Ahmad F. 2008. Zinc alpha 2-glycoprotein: a multidisciplinary protein. Mol Cancer Res. 6(6):892–906. doi:10.1158/1541-7786.MCR-07-2195.
  • Horvath AJ, Irving JA, Rossjohn J, Law RH, Bottomley SP, Quinsey NS, Pike RN, Coughlin PB, Whisstock JC. 2005. The murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins. J Biol Chem. 280(52):43168–43178. doi:10.1074/jbc.M505598200.
  • Howren MB, Lamkin DM, Suls J. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 71(2):171–186. doi:10.1097/PSY.0b013e3181907c1b.
  • Hunter EC, Charlton J, David AS. 2017. Depersonalisation and derealisation: assessment and management. BMJ. 356:j745. doi:10.1136/bmj.j745.
  • Joseph K, Shibayama Y, Ghebrehiwet B, Kaplan AP. 2001. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1. Thromb Haemost. 85(01):119–124. doi:10.1055/s-0037-1612914.
  • Kerezoudis P, Howe CL, Wu L-J, Lundstrom BN, Van Gompel JJ. 2022. Insula and the immune system: more than mere Co-existence? Neurosci Bull. 38(10):1271–1273. doi:10.1007/s12264-022-00911-z.
  • Koren T, Yifa R, Amer M, Krot M, Boshnak N, Ben-Shaanan TL, Azulay-Debby H, Zalayat I, Avishai E, Hajjo H, et al. 2021. Insular cortex neurons encode and retrieve specific immune responses. Cell. 184(24):5902–5915.e5917. doi:10.1016/j.cell.2021.10.013.
  • Lane EB, McLean WH. 2004. Keratins and skin disorders. J Pathol. 204(4):355–366. doi:10.1002/path.1643.
  • Lannan EA, Galliher-Beckley AJ, Scoltock AB, Cidlowski JA. 2012. Proinflammatory actions of glucocorticoids: glucocorticoids and TNFα coregulate gene expression in vitro and in vivo. Endocrinology. 153(8):3701–3712. doi:10.1210/en.2012-1020.
  • Lemche E, Brammer MJ, David AS, Surguladze SA, Phillips ML, Sierra M, Williams SCR, Giampietro VP. 2013. Interoceptive-reflective regions differentiate alexithymia traits in depersonalization disorder. Psychiatry Res. 214(1):66–72. doi:10.1016/j.pscychresns.2013.05.006.
  • Liang Y, Jiang XC, Liu R, Liang G, Beyer TP, Gao H, Ryan TP, Dan Li S, Eacho PI, Cao G. 2004. Liver X receptors (LXRs) regulate apolipoprotein AIV-implications of the antiatherosclerotic effect of LXR agonists. Mol Endocrinol. 18(8):2000–2010. doi:10.1210/me.2003-0477.
  • Liu S, Pan J, Tang K, Lei Q, He L, Cai X, Li Z. 2021. Alpha 1-antichymotrypsin may be a biomarker for the progression of amnestic mild cognitive impairment. Acta Neurol Belg. 121(2):451–464. doi:10.1007/s13760-019-01206-3.
  • Mallick P, Kuster B. 2010. Proteomics: a pragmatic perspective. Nat Biotechnol. 28(7):695–709. doi:10.1038/nbt.1658.
  • Månsson KNT, Lasselin J, Karshikoff B, Axelsson J, Engler H, Schedlowski M, Benson S, Petrovic P, Lekander M. 2022. Anterior insula morphology and vulnerability to psychopathology-related symptoms in response to acute inflammation. Brain Behav Immun. 99:9–16. doi:10.1016/j.bbi.2021.09.007.
  • Mehta ND, Stevens JS, Li Z, Gillespie CF, Fani N, Michopoulos V, Felger JC. 2020. Inflammation, reward circuitry and symptoms of anhedonia and PTSD in trauma-exposed women. Soc Cogn Affect Neurosci. 15(10):1046–1055. doi:10.1093/scan/nsz100.
  • Michal M, Adler J, Wiltink J, Reiner I, Tschan R, Wölfling K, Weimert S, Tuin I, Subic-Wrana C, Beutel ME, et al. 2016. A case series of 223 patients with depersonalization-derealization syndrome. BMC Psychiatry. 16(1):203. doi:10.1186/s12888-016-0908-4.
  • Milaneschi Y, Kappelmann N, Ye Z, Lamers F, Moser S, Jones PB, Burgess S, Penninx B, Khandaker GM. 2021. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK biobank and NESDA cohorts. Mol Psychiatry. 26(12):7393–7402. doi:10.1038/s41380-021-01188-w.
  • Moll R, Divo M, Langbein L. 2008. The human keratins: biology and pathology. Histochem Cell Biol. 129(6):705–733. doi:10.1007/s00418-008-0435-6.
  • Morey, R. D., & Rouder, J. N. 2024. BayesFactor: Computation of bayes factors for common designs [Manual]. https://CRAN.R-project.org/package=BayesFactor
  • Naudé PJW, Roest AM, Stein DJ, de Jonge P, Doornbos B. 2018. Anxiety disorders and CRP in a population cohort study with 54,326 participants: the LifeLines study. World J Biol Psychiatry. 19(6):461–470. doi:10.1080/15622975.2018.1433325.
  • Noda M, Kariura Y, Pannasch U, Nishikawa K, Wang L, Seike T, Ifuku M, Kosai Y, Wang B, Nolte C, et al. 2007. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J Neurochem. 101(2):397–410. doi:10.1111/j.1471-4159.2006.04339.x.
  • Phillips ML, Sierra M. 2003. Depersonalization disorder: a functional neuroanatomical perspective. Stress. 6(3):157–165. doi:10.1080/1025389031000138538.
  • Pixley RA, Espinola RG, Ghebrehiwet B, Joseph K, Kao A, Bdeir K, Cines DB, Colman RW. 2011. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore). Thromb Haemost. 105(6):1053–1059.
  • Recalde D, Ostos MA, Badell E, Garcia-Otin AL, Pidoux J, Castro G, Zakin MM, Scott-Algara D. 2004. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide. Arterioscler Thromb Vasc Biol. 24(4):756–761. doi:10.1161/01.ATV.0000119353.03690.22.
  • Ross CA, Duffy CMM, Ellason JW. 2002. Prevalence, reliability and validity of dissociative disorders in an inpatient setting. J Trauma Dissociation. 3(1):7–17. doi:10.1300/J229v03n01_02.
  • Roydeva MI, Reinders A. 2021. Biomarkers of pathological dissociation: a systematic review. Neurosci Biobehav Rev. 123:120–202. doi:10.1016/j.neubiorev.2020.11.019.
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini-International neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 59 Suppl 20:22–33. quiz 34-57.
  • Shuken SR. 2023. An introduction to mass spectrometry-based proteomics. J Proteome Res. 22(7):2151–2171. doi:10.1021/acs.jproteome.2c00838.
  • Sierra M. 2008. Depersonalization disorder: pharmacological approaches. Expert Rev Neurother. 8(1):19–26. doi:10.1586/14737175.8.1.19.
  • Sierra M, Berrios GE. 1998. Depersonalization: neurobiological perspectives. Biol Psychiatry. 44(9):898–908. doi:10.1016/s0006-3223(98)00015-8.
  • Sierra, M., & Berrios, G. E. 2000. The Cambridge Depersonalization Scale: A new instrument for the measurement of depersonalization. Psychiatry Research, 93(2), 153–164. doi: 10.1016/s0165-1781(00)00100-1.
  • Sierra M, Senior C, Dalton J, McDonough M, Bond A, Phillips ML, O'Dwyer AM, David AS. 2002. Autonomic response in depersonalization disorder. Arch Gen Psychiatry. 59(9):833–838. doi:10.1001/archpsyc.59.9.833.
  • Sierra M, Senior C, Phillips ML, David AS. 2006. Autonomic response in the perception of disgust and happiness in depersonalization disorder. Psychiatry Res. 145(2-3):225–231. doi:10.1016/j.psychres.2005.05.022.
  • Simeon D. 2004. Depersonalisation disorder: a contemporary overview. CNS Drugs. 18(6):343–354. doi:10.2165/00023210-200418060-00002.
  • Simeon D, Guralnik O, Hazlett EA, Spiegel-Cohen J, Hollander E, Buchsbaum MS. 2000. Feeling unreal: a PET study of depersonalization disorder. Am J Psychiatry. 157(11):1782–1788. doi:10.1176/appi.ajp.157.11.1782.
  • Simeon D, Guralnik O, Knutelska M, Hollander E, Schmeidler J. 2001. Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder. Neuropsychopharmacology. 25(5):793–795. doi:10.1016/S0893-133X(01)00288-3.
  • Simeon D, Guralnik O, Knutelska M, Yehuda R, Schmeidler J. 2003. Basal norepinephrine in depersonalization disorder. Psychiatry Res. 121(1):93–97. doi:10.1016/s0165-1781(03)00205-1.
  • Simeon D, Knutelska M, Nelson D, Guralnik O. 2003. Feeling unreal: a depersonalization disorder update of 117 cases. J Clin Psychiatry. 64(9):990–997. doi:10.4088/jcp.v64n0903.
  • Simeon D, Knutelska M, Putnam FW, Schmeidler J, Smith LM. 2023. Attention and memory in depersonalization-Spectrum dissociative disorders: impact of Selective-Divided attentional condition, stimulus emotionality, and stress. J Trauma Dissociation. 24(1):42–62. doi:10.1080/15299732.2022.2079798.
  • Simeon D, Knutelska M, Yehuda R, Putnam F, Schmeidler J, Smith LM. 2007. Hypothalamic-pituitary-adrenal axis function in dissociative disorders, post-traumatic stress disorder, and healthy volunteers. Biol Psychiatry. 61(8):966–973. doi:10.1016/j.biopsych.2006.07.030.
  • Spiegel D, Lewis-Fernández R, Lanius R, Vermetten E, Simeon D, Friedman M. 2013. Dissociative disorders in DSM-5. Annu Rev Clin Psychol. 9(1):299–326. doi:10.1146/annurev-clinpsy-050212-185531.
  • Stanton BR, David AS, Cleare AJ, Sierra M, Lambert MV, Phillips ML, Porter RJ, Gallagher P, Young AH. 2001. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with depersonalization disorder. Psychiatry Res. 104(1):85–89. doi:10.1016/s0165-1781(01)00291-8.
  • Tada T, Ohkubo I, Niwa M, Sasaki M, Tateyama H, Eimoto T. 1991. Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues. J Histochem Cytochem. 39(9):1221–1226. doi:10.1177/39.9.1918940.
  • Tiyekli U, Calıyurt O, Tiyekli ND. 2013. Proinflammatory cytokine levels in patients with conversion disorder. Acta Neuropsychiatr. 25(3):137–143. doi:10.1111/j.1601-5215.2012.00676.x.
  • Vesuna S, Kauvar IV, Richman E, Gore F, Oskotsky T, Sava-Segal C, Luo L, Malenka RC, Henderson JM, Nuyujukian P, et al. 2020. Deep posteromedial cortical rhythm in dissociation. Nature. 586(7827):87–94. doi:10.1038/s41586-020-2731-9.
  • Vowinkel T, Mori M, Krieglstein CF, Russell J, Saijo F, Bharwani S, Turnage RH, Davidson WS, Tso P, Granger DN, et al. 2004. Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest. 114(2):260–269. doi:10.1172/JCI200421233.
  • Walker AJ, Foley BM, Sutor SL, McGillivray JA, Frye MA, Tye SJ. 2015. Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance. Behav Brain Res. 293:198–202. doi:10.1016/j.bbr.2015.07.026.
  • Yang J, Millman LSM, David AS, Hunter ECM. 2023. The prevalence of depersonalization-derealization disorder: a systematic review. J Trauma Dissociation. 24(1):8–41. doi:10.1080/15299732.2022.2079796.
  • Zhang Y, He J, Zhao J, Xu M, Lou D, Tso P, Li Z, Li X. 2017. Effect of ApoA4 on SERPINA3 mediated by nuclear receptors NR4A1 and NR1D1 in hepatocytes. Biochem Biophys Res Commun. 487(2):327–332. doi:10.1016/j.bbrc.2017.04.058.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.